Open the mobile version, with barcode scanning
Class II Ongoing

fentaNYL Citrate Injectable Solution, Narcotic, CII, 1250 mcg/25mL (50 mcg per mL), 25 mL, wells pharma of Houston, NDC 73702-204-25.

Why: cGMP deviations.

Company
Wells Pharma of Houston LLC
Houston, TX, United States
Reported
May 6, 2026
Recall started
Apr 1, 2026
Where sold
U.S. Nationwide.
Amount
50 syringes
Full product description
fentaNYL Citrate Injectable Solution, Narcotic, CII, 1250 mcg/25mL (50 mcg per mL), 25 mL, wells pharma of Houston, NDC 73702-204-25.
Lots / codes affected
Lot 011226204250063, Exp Date 05/14/2026

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.